Jeffrey S. Epstein, M.D., FACS, Founder and Director of the Foundation for Hair Restoration, has been in private practice since 1994. He is triple board certified by the American Board of Facial Plastic and Reconstructive Surgery, the American Board of Hair Restoration Surgery, and the American Board of Otolaryngology/Head and Neck Surgery. In addition to his busy clinical practice, where he personally performs all his surgeries in his accredited office facility, he is a Voluntary Clinical Professor at the University of Miami, and Past President of the Florida Society of Facial Plastic and Reconstructive Surgery. He publishes and lectures extensively,
Jeffrey S. Epstein, M.D., FACS, Founder and Director of the Foundation for Hair Restoration, has been in private practice since 1994. He is triple board certified by the American Board of Facial Plastic and Reconstructive Surgery, the American Board of Hair Restoration Surgery, and the American Board of Otolaryngology/Head and Neck Surgery. In addition to his busy clinical practice, where he personally performs all his surgeries in his accredited office facility, he is a Voluntary Clinical Professor at the University of Miami, and Past President of the Florida Society of Facial Plastic and Reconstructive Surgery. He publishes and lectures extensively, is frequently featured in the media and press, and is considered a foremost expert in his specialty. Given his work in hair restoration, he has particular interest in more experimental areas of hair and hair loss, including the use of cell therapies.
Dr. Timothy Falla is the Chief Scientific Officer at Rodan + Fields. For over 25 years Dr. Falla has worked in the discovery and development of prescription drugs, OTC dermatology products and skincare products and has been with Rodan + Fields since 2011. Previously he served as CSO of Helix BioMedix Inc., where he was responsible for introducing innovative technologies into more than 100 dermatological products targeting acne, rosacea, hyper-pigmentation, photoaging and inflammation. His work has resulted in more than 30 patents and patent applications and over 100 peer reviewed publications. Dr. Falla holds a Bachelor of Science in Applied
Dr. Timothy Falla is the Chief Scientific Officer at Rodan + Fields. For over 25 years Dr. Falla has worked in the discovery and development of prescription drugs, OTC dermatology products and skincare products and has been with Rodan + Fields since 2011. Previously he served as CSO of Helix BioMedix Inc., where he was responsible for introducing innovative technologies into more than 100 dermatological products targeting acne, rosacea, hyper-pigmentation, photoaging and inflammation. His work has resulted in more than 30 patents and patent applications and over 100 peer reviewed publications. Dr. Falla holds a Bachelor of Science in Applied Biology and a PhD in Molecular Epidemiology.His Research interests are Basic and applied research in the development of therapeutic products in the areas of skin aging, hyperpigmentation, sensitivity and acne. Including formulated cosmetic and OTC products, tools and devices and diagnostics.
Dr. Jane M. Grant-Kels is founding chair of the Division and then Department of Dermatology at the University of Connecticut Health Center as well as Professor of Dermatology, Pathology and Pediatrics. She is director of the dermatology residency program which she played a major role in creating in 2007, director of the dermatopathology laboratory and the director of both the Cutaneous Oncology Center and Melanoma Program. She is also Assistant Dean of Clinical Affairs. Dr. Grant-Kels received a BA Degree in 1971 from Smith College and her Medical Degree from Cornell University Medical College in 1974. She trained in pediatrics
Dr. Jane M. Grant-Kels is founding chair of the Division and then Department of Dermatology at the University of Connecticut Health Center as well as Professor of Dermatology, Pathology and Pediatrics. She is director of the dermatology residency program which she played a major role in creating in 2007, director of the dermatopathology laboratory and the director of both the Cutaneous Oncology Center and Melanoma Program. She is also Assistant Dean of Clinical Affairs. Dr. Grant-Kels received a BA Degree in 1971 from Smith College and her Medical Degree from Cornell University Medical College in 1974. She trained in pediatrics and dermatology at The New York Hospital of Cornell Medical Center. She then completed a dermatopathology fellowship at NYU under the direction of A. Bernard Ackerman. She serves on numerous boards and editorial boards related to her field. She is the founding editor in chief of the Journal of Clinical Medicine and founding co-editor in chief of the International Journal of Women's Dermatology. She has published over 225 manuscripts, 80 chapters, guest edited 18 journals, and edited or co-authored 6 books. She is presently a member of the Board of the Women's Dermatologic Society and the Board of the American Academy of Dermatology. My area of interest is pigmented lesions.
Daniel E. Furst is Professor of Medicine at the University of California (Emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. Dr. Furst is also Adjunct Professor at the University of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy. He has part time practices at the Arthritis Associates of Southern California and the Seattle Rheumatology Associates in Seattle Washington. Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and
Daniel E. Furst is Professor of Medicine at the University of California (Emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. Dr. Furst is also Adjunct Professor at the University of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy. He has part time practices at the Arthritis Associates of Southern California and the Seattle Rheumatology Associates in Seattle Washington. Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and a second in clinical pharmacology at the University of California, San Francisco Medical Center. After serving as assistant professor of medicine/rheumatology at the UCLA Medical Center and associate professor of internal medicine/Rheumatology at the University of Iowa Carver College of Medicine. He became clinical professor in the Department of Medicine, Division of Rheumatology and Connective Tissue Research at the University of Medicine and Dentistry of New Jersey, and director of AI/P Clinical Research at Ciba Geigy Pharmaceuticals. He then moved to Seattle, where he was clinical professor of medicine at the University of Washington, then director of clinical research programs and director of the Arthritis Clinical Research Unit at the Virginia Mason Medical Center. He took up his position at UCLA in 2002 and became emeritus in 2015. At that time, he took on his several other positions and practices (Univ of Washington; University of Florence; 2 part time practices -LA and Seattle), thus both enlarging his research and clinical practices. Dr. Furst's research interests center on the clinical pharmacology of antirheumatic drugs and biologics, and on the pathophysiology and treatment of progressive systemic sclerosis. He is on the national medical advisory board of the Scleroderma Foundation, the scientific advisory board of the Arthritis Foundation, is vice-president of the Southern California Chapter of the Scleroderma Foundation, is on the Board of Directors of the Arhtirtis Foundation of Southern California and the board of directors for the foundation of the Collaboration of Research Rheumatologists of North America. He has written over 950 original articles/reviews/chapters and written or Edited 14 books on rheumatic diseases.
David E. Fisher, MD, PhD, a laboratory researcher, clinician and academic, is Chief of the Massachusetts General Hospital Department of Dermatology, Director of the MGH Cutaneous Biology Research Center and Director of the Melanoma Center at MGH. A Professor of Dermatology and of Pediatrics at Harvard Medical School, Fisher came to the MGH from the Dana-Farber Cancer Institute, where he previously directed the Melanoma Program. He obtained undergraduate degrees at Swarthmore College and the Curtis Institute of Music, his MD at Cornell, and PhD at Rockefeller University (labs of Henry Kunkel and Gunter Blobel). He trained clinically in Internal Medicine at
David E. Fisher, MD, PhD, a laboratory researcher, clinician and academic, is Chief of the Massachusetts General Hospital Department of Dermatology, Director of the MGH Cutaneous Biology Research Center and Director of the Melanoma Center at MGH. A Professor of Dermatology and of Pediatrics at Harvard Medical School, Fisher came to the MGH from the Dana-Farber Cancer Institute, where he previously directed the Melanoma Program. He obtained undergraduate degrees at Swarthmore College and the Curtis Institute of Music, his MD at Cornell, and PhD at Rockefeller University (labs of Henry Kunkel and Gunter Blobel). He trained clinically in Internal Medicine at Mass. General Hospital, and in Medical and Pediatric Oncology at Dana-Farber and Children's Hospital, followed by postdoctoral research with Dr. Phillip Sharp (MIT). Dr. Fisher's research focuses on biochemical mechanisms of gene transcription, developmental biology of melanocytes, and molecular mechanisms of melanoma formation and treatment.
Dr. Beom Joon Kim is a head professor in the Department of Dermatology at Chung-Ang university medical center. He received his medical degree from College of Medicine, Chung-Ang University in Korea. And He was completed Doctorate of Philosophy in 2007 at Dermatology of Chung-Ang University. He has been appointed to be a editorial in many international journals such as Journal of the American Academy of Dermatology and International Journal of Dermatology from 2008 to 2013. Also, He published about 60 SCI leveled papers. In 2007, he received Dr. Paul Janssen Award, Korean Dermatological Association. He was selected as International Health
Dr. Beom Joon Kim is a head professor in the Department of Dermatology at Chung-Ang university medical center. He received his medical degree from College of Medicine, Chung-Ang University in Korea. And He was completed Doctorate of Philosophy in 2007 at Dermatology of Chung-Ang University. He has been appointed to be a editorial in many international journals such as Journal of the American Academy of Dermatology and International Journal of Dermatology from 2008 to 2013. Also, He published about 60 SCI leveled papers. In 2007, he received Dr. Paul Janssen Award, Korean Dermatological Association. He was selected as International Health Professional of the Year 2007, International Biographical Center, Cambridge, England. In addition, he act on committee for Medical Equipment Board, Korea Food and Drug Administration of Korea and perform project Manager board member, Korea Health Industry Development Institute. As a professor-educator he dedicated himself to pass on his knowledge he had gained his experience to his student and improve welfare of his patient as doctor.
Professor Ahmad Awada studied Medicine at the Universite Libre de Bruxelles (ULB), Belgium. He did a specialisation in Internal Medicine and Medical Oncology at Jules Bordet Institute (under the supervision of Professor Jean Klastersky), in Brussels, until 1992 ('La plus grande distinction'). During his specialisation, he also followed trainings in the clinical development of new therapies and new anticancer drugs, mainly in breast cancer under the supervision of Professor Martine Piccart. To deepen his training, he stayed in the Netherlands (New Drug Development Office, Free University, Amsterdam) and in San Antonio, USA (Institute for Drug Development, under the direction of
Professor Ahmad Awada studied Medicine at the Universite Libre de Bruxelles (ULB), Belgium. He did a specialisation in Internal Medicine and Medical Oncology at Jules Bordet Institute (under the supervision of Professor Jean Klastersky), in Brussels, until 1992 ('La plus grande distinction'). During his specialisation, he also followed trainings in the clinical development of new therapies and new anticancer drugs, mainly in breast cancer under the supervision of Professor Martine Piccart. To deepen his training, he stayed in the Netherlands (New Drug Development Office, Free University, Amsterdam) and in San Antonio, USA (Institute for Drug Development, under the direction of Professor D. Von Hoff). He focused on the clinical development of new anticancer agents in solid tumors. Back from the USA at the beginning of 1994, Doctor Awada became Assistant Head of Medical Oncology Clinic, and Head of the New Drugs Development Unit at Jules Bordet Institute, Brussels. Since April 2005, he is the Head of the Medical Oncology at Jules Bordet Cancer Institute. In addition and from 1st March 2011, Dr. Awada was hold Associate Head of Medicine Department. He has an important clinical activity in the treatment of solid tumors. Doctor Awada took an active part in the development of new anticancer drugs in solid tumors, some of them already widely used. Thanks to the progress in technology and computer sciences, and consequently in molecular biology, we can understand better now the biology of cancer. Many drugs are now studied to block this process. Those are the molecular-targeted therapies, a subject studied extensively in clinical research by Doctor Awada and were the basis for this thesis obtained from the ULB, Brussels, in 2004. The aim of Doctor Awada, as far as research is concerned, is to look for new active anticancer drugs in solid tumors (new cytotoxics and molecular targeted therapies), and to individualize the treatments of cancer patients.
Robin L. Thurmond, Ph.D. is the Early Development Portfolio Leader for Rheumatology and Psoriasis with the Clinical Research group at Janssen Research & Development in La Jolla, CA. Prior to that he was a Research Fellow with the Immunology Drug Discovery group at the same site. Dr. Thurmond's research involves investigation of novel mechanisms of action targeting new anti-inflammatory medicines for diseases such as asthma, atopic dermatitis and rheumatoid arthritis. Dr. Thurmond is a recognized expert in histamine receptors and their role in inflammation with over 90 scientific articles, reviews and book chapters as well as the editor of a
Robin L. Thurmond, Ph.D. is the Early Development Portfolio Leader for Rheumatology and Psoriasis with the Clinical Research group at Janssen Research & Development in La Jolla, CA. Prior to that he was a Research Fellow with the Immunology Drug Discovery group at the same site. Dr. Thurmond's research involves investigation of novel mechanisms of action targeting new anti-inflammatory medicines for diseases such as asthma, atopic dermatitis and rheumatoid arthritis. Dr. Thurmond is a recognized expert in histamine receptors and their role in inflammation with over 90 scientific articles, reviews and book chapters as well as the editor of a book on histamine in inflammation.He received his B.A. in Chemistry from the University of Virginia and his Ph.D. in Biochemistry from the University of Arizona. Dr. Thurmond studied membrane biophysics at the University of Arizona and worked on the molecular aspects of rhodopsin function during his postdoctoral training at the Massachusetts Institute of Technology with Dr. Gobind Khorana, Nobel Laurate 1968. He began his career with Johnson & Johnson in 1996 at the R.W. Johnson Pharmaceutical Research Institute in Raritan N.J. and has been with Johnson & Johnson for 20 years.
Dr. Eve Lowenstein grew up in Israel and Long Island. She graduated with highest honors from Queens College, having majored in Chemistry and literature, religion and philosophy of the Western Tradition. She completed the New York University School of Medicine's Medical Scientist Training Program, where she earned a MS (1992), a PhD (1994) in Cellular and Molecular Biology and her MD (1995). As a graduate student, Dr. Lowenstein made a significant discovery of the gene Grb-2, important in cell signaling and cancer growth. Dr. Lowenstein was Chief of Dermatology at Brookdale University Hospital for over 7 years. She is
Dr. Eve Lowenstein grew up in Israel and Long Island. She graduated with highest honors from Queens College, having majored in Chemistry and literature, religion and philosophy of the Western Tradition. She completed the New York University School of Medicine's Medical Scientist Training Program, where she earned a MS (1992), a PhD (1994) in Cellular and Molecular Biology and her MD (1995). As a graduate student, Dr. Lowenstein made a significant discovery of the gene Grb-2, important in cell signaling and cancer growth. Dr. Lowenstein was Chief of Dermatology at Brookdale University Hospital for over 7 years. She is currently Director of Medical Dermatology at SUNY Health Science Center in Brooklyn and Kings Count Hospital, where she is involved in resident education. She is also an Associate of South Nassau Dermatology PC, at its offices in Oceanside and Long Beach, New York. She has authored over forty research articles and three book chapters, is on the editorial board of 17 journals. Her primary areas of research interests include acne, history of medicine and forensics in dermatology. She serves on numerous journal editorial boards and committees of national dermatology organizations. She has won awards, honors and grants, including an Outstanding Physician Award at Kings County Hospital.
Professor Georgi Tchernev graduated his medical education in 2001 at the American University 'Benjamin Franklin' in West Berlin. Then applied and was approved for a PhD student in the Department of Dermatology, Venereology and Allergology under the leadership of Prof. Dr. Constantin Orfanos and Prof. Dr. Christoph Geilen. During this time he worked in parallel and as an assistant doctor/resident at the University Hospital Benjamin Franklin, Departments of Dermatology, Venereology and Allergology. From 2004 to early 2006, he is resident in the Departments of Dermatology, Venereology, Allergology and Immunology Municipal Hospital Dessau, Academic Teaching Hospital of the University 'Martin Luther'
Professor Georgi Tchernev graduated his medical education in 2001 at the American University 'Benjamin Franklin' in West Berlin. Then applied and was approved for a PhD student in the Department of Dermatology, Venereology and Allergology under the leadership of Prof. Dr. Constantin Orfanos and Prof. Dr. Christoph Geilen. During this time he worked in parallel and as an assistant doctor/resident at the University Hospital Benjamin Franklin, Departments of Dermatology, Venereology and Allergology. From 2004 to early 2006, he is resident in the Departments of Dermatology, Venereology, Allergology and Immunology Municipal Hospital Dessau, Academic Teaching Hospital of the University 'Martin Luther' in Halle-Wittenberg, under the leadership of Prof. Dr. Hans-Dieter Goering and later Prof. Dr. Christos Zouboulis. In 2007, he finished his PhD work in the field of dermatology and oncology and continues to be resident in the Departments of Dermatology, Venereology, Allergology and Pediatric Pulmonology in Kuhlungsborn, Germany. He acquires specialty Dermatology and Venereology in 2008. From 2008-2010 Dr. Tchernev actively work for the creation and establishment of Policlinic in Dermatology and Dermatologic Surgery in Kirchheim, Germany. In 2010, Dr. Tchernev receive academic degree 'Associate Profesor' of Dermatology at the Faculty of Medicine at the Thracian University in Stara Zagora, Department of Dermatology and Venereology. From 2011 to present he is an Associate Professor of Dermatology at the Policlinic of the University Hospital Lozenets- Academic Teaching Hospital of the Sofia University 'St. Kliment Ohridski'. At the meantime, he is a creator and owner of a private Policlinic for Dermatology and Dermatologic Surgery, named 'Onkoderma', located in Sofia, Bulgaria. His scientific interests are focused in the field of dermatologic surgery, dermatologic oncology, pathogenesis of immunologically mediated diseases in dermatology and theoretical and practical immunology. Prof Dr Tchernev is serving as Professore a Contratto in the University G.Marconi of Rome in the present Academic Year 2015-2016. Prof. Tchernev is an author of more than 300 scientific works, including over 220 articles published in international (and some Bulgarian) journals, including the The New England Journal of Medicine and The Journal of Investigative Dermatology,The Lancet, Mayo Clinic Proceedings, Medicine (Baltimore), publisher and co-author of three books, with over 40 chapters in total and is a regular participant in national and international forums and congresses of Dermatology all over the world. Since march 2016 Georgi Tchernev is Professor at the Medical Institute, Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery.
Dr. Ivana L. de la Serna is an Associate Professor at the University of Toledo College Of Medicine and Life Sciences, Department of Biochemistry and Cancer Biology. Her research interests: In eukaryotes, DNA is packaged into chromatin, the basic unit of which is the nucleosome. SWI or SNF enzymes are multiprotein complexes that alter chromatin structure in an ATP dependent manner and are involved in the regulation of gene expression. Components of the SWI or SNF complex are essential for mouse development and play important roles in several human cancers. To better understand the mechanisms by which SWI or SNF
Dr. Ivana L. de la Serna is an Associate Professor at the University of Toledo College Of Medicine and Life Sciences, Department of Biochemistry and Cancer Biology. Her research interests: In eukaryotes, DNA is packaged into chromatin, the basic unit of which is the nucleosome. SWI or SNF enzymes are multiprotein complexes that alter chromatin structure in an ATP dependent manner and are involved in the regulation of gene expression. Components of the SWI or SNF complex are essential for mouse development and play important roles in several human cancers. To better understand the mechanisms by which SWI or SNF activity regulates cellular differentiation and how this activity is perturbed in human cancers, Dr. de la Serna's lab has focused on SWI or SNF function in differentiating melanocyte precursors and in melanoma. She also works on projects that investigate SWI or SNF function during muscle differentiation and in rhabdomyoscarcoma. Regulation of melanocyte differentiation by SWI or SNF enzymes: Melanocytes are cells derived from the neural crest that migrate to the skin and provide protection against damage from ultraviolet light by synthesizing the pigment, melanin. Melanocyte precursors isolated from newborn mouse skin are pleuripotent. Dr. de la Serna is currently investigating the mechanisms by which SWI or SNF enzymes regulate transcription factor function and interact with other chromatin remodeling enzymes to promote differentiation of precursor cells along the glial or melanocyte lineages. These studies will have implications for utilizing skin cells in regenerative medicine and for developing strategies for skin cancer prevention.
Eduardo Nagore, is an Associate professor at the Universidad Catolica of Valencia, Spain. Dermatologist since 1997, received his Ph.D. (in Medical Sciences) from the Universitat de Valencia in 2007. His clinical practice takes place at the Instituto Valenciano de Oncologia, an oncology center where has developed most of his professional career. His research interest and area of expertise is skin cancer, particularly melanoma. His research work has resulted in 160 peer-reviewed papers.
Eduardo Nagore, is an Associate professor at the Universidad Catolica of Valencia, Spain. Dermatologist since 1997, received his Ph.D. (in Medical Sciences) from the Universitat de Valencia in 2007. His clinical practice takes place at the Instituto Valenciano de Oncologia, an oncology center where has developed most of his professional career. His research interest and area of expertise is skin cancer, particularly melanoma. His research work has resulted in 160 peer-reviewed papers.
Salvador Gonzalez, accredited Full Professor by the Quality and Accreditation Evaluation Spanish Agency, serves as Associate Professor of Medicine Department at Alcala University in Madrid, Spain and Visiting Faculty Member in the Dermatology Service at the Memorial Sloan-Kettering Cancer Center in New York, USA, and. Before, he also joined the faculty of the Dermatology Department at Harvard Medical School, Boston for over 10 years. Dr Gonzalez research interests focused on skin cancer chemoprevention, photoprotection and optical diagnoses. His scientific contribution has a hirsch factor of 29, a total number of citations of 2,421 and an accumulated total impact
Salvador Gonzalez, accredited Full Professor by the Quality and Accreditation Evaluation Spanish Agency, serves as Associate Professor of Medicine Department at Alcala University in Madrid, Spain and Visiting Faculty Member in the Dermatology Service at the Memorial Sloan-Kettering Cancer Center in New York, USA, and. Before, he also joined the faculty of the Dermatology Department at Harvard Medical School, Boston for over 10 years. Dr Gonzalez research interests focused on skin cancer chemoprevention, photoprotection and optical diagnoses. His scientific contribution has a hirsch factor of 29, a total number of citations of 2,421 and an accumulated total impact factor of 390.933. He leads systemic photoprotection and non-invasive optical diagnosis. To this end, he was the founder and is the President of the International Confocal Group. His research work has been recognized by various US institutions and societies (Skin Cancer Foundation; National Institutes of Human Resources, among others), and has resulted in over 200 peer-reviewed papers, and over 30 book chapters, being the Editor of three books which have contributed to spreading his scientific knowledge and expertise throughout the medical community.
Yanhua Liang, M.D., Ph.D., Associate Professor in the Department of Dermatology, Nanfang Hospital at Southern Medical University, China, received his Ph.D in Dermatology in 2007. He had his 2-year postdoctoral training at The Jackson Laboratory U.S.A before jointing the faculty of Yale University School of Medicine in 2010. He has identified CYLD1 gene as the disease gene of multiple familiar trichoepithelioma, and XBP1 as genetic risk factor for vitiligo in Chinese Hans. He has done in-depth research to understand the biological function of SHARPIN. Except for molecular basical studies, he has also developed new biological materials and techniques for transdermal
Yanhua Liang, M.D., Ph.D., Associate Professor in the Department of Dermatology, Nanfang Hospital at Southern Medical University, China, received his Ph.D in Dermatology in 2007. He had his 2-year postdoctoral training at The Jackson Laboratory U.S.A before jointing the faculty of Yale University School of Medicine in 2010. He has identified CYLD1 gene as the disease gene of multiple familiar trichoepithelioma, and XBP1 as genetic risk factor for vitiligo in Chinese Hans. He has done in-depth research to understand the biological function of SHARPIN. Except for molecular basical studies, he has also developed new biological materials and techniques for transdermal gene delivery, and modified in vivo models for hair follicle reconstitution. He has established a translational skin research program with major focus on gene identification, gene function and gene correction for genodermatitis. Dr. Liang is the author of more than 60 peer reviewed publications.
Megan Morrison is an Assistant Clinical Professor of Dermatology at Michigan State University. Dr. Morrison specializes in Mohs Micrographic Surgery and has been invited to lecture at multiple National and State conferences. Dr. Morrison completed her Residency in Dermatology and Fellowship in Mohs Surgery at St. Joseph Mercy Hospital. Dr. Morrison has published many manuscripts, is a guest editor for multiple journals and has coauthored a book on Occupational Dermatology. Dr. Morrison is presently a member of the American Osteopathic College of Dermatology, the American Academy of Dermatology and the American Society of Mohs Surgeons. Dr. Morrison's research focuses on
Megan Morrison is an Assistant Clinical Professor of Dermatology at Michigan State University. Dr. Morrison specializes in Mohs Micrographic Surgery and has been invited to lecture at multiple National and State conferences. Dr. Morrison completed her Residency in Dermatology and Fellowship in Mohs Surgery at St. Joseph Mercy Hospital. Dr. Morrison has published many manuscripts, is a guest editor for multiple journals and has coauthored a book on Occupational Dermatology. Dr. Morrison is presently a member of the American Osteopathic College of Dermatology, the American Academy of Dermatology and the American Society of Mohs Surgeons. Dr. Morrison's research focuses on new therapies for nonmelanoma skin cancer and melanoma epidemiology.
Emma Taylor, M.D. is an Assistant Clinical Professor of Dermatology and Dermatopathology at UCLA. She has been involved in research investigating the beneficial properties of natural products, such as resveratrol in grapes for acne, which resulted in an international patent application. She has published in high impact journals such as Nature, Journal of the American Academy of Dermatology, and Dermatology and Therapy. She has been featured in Science World Report, WebMD, Dermatology Times, Glamour, Huffington Post, Women's Health magazine, Men's Health Magazine, Fox News, and more for her for her expertise in dermatology. She is currently involved in research relating
Emma Taylor, M.D. is an Assistant Clinical Professor of Dermatology and Dermatopathology at UCLA. She has been involved in research investigating the beneficial properties of natural products, such as resveratrol in grapes for acne, which resulted in an international patent application. She has published in high impact journals such as Nature, Journal of the American Academy of Dermatology, and Dermatology and Therapy. She has been featured in Science World Report, WebMD, Dermatology Times, Glamour, Huffington Post, Women's Health magazine, Men's Health Magazine, Fox News, and more for her for her expertise in dermatology. She is currently involved in research relating to tumor response for novel melanoma therapeutics, investigating new acne therapeutics, and skin cancer prevention.
Daisuke Onozuka is an Assistant Professor of the Department of Health Care Administration and Management at the Kyushu University Graduate School of Medical Sciences. Dr. Onozuka received his Ph.D. (in Medical Sciences) from the Kyushu University Graduate School of Medical Sciences, Japan. He was previously in the Department of Public Health and Medical Affairs at Fukuoka Prefectural Government, and Fukuoka Institute of Health and Environmental Sciences. His area of expertise pertain to infectious disease epidemiology and Yusho disease. My research interests cover most of environmental epidemiology. Current substantive research topics of interest, on which my work in collaboration with both
Daisuke Onozuka is an Assistant Professor of the Department of Health Care Administration and Management at the Kyushu University Graduate School of Medical Sciences. Dr. Onozuka received his Ph.D. (in Medical Sciences) from the Kyushu University Graduate School of Medical Sciences, Japan. He was previously in the Department of Public Health and Medical Affairs at Fukuoka Prefectural Government, and Fukuoka Institute of Health and Environmental Sciences. His area of expertise pertain to infectious disease epidemiology and Yusho disease. My research interests cover most of environmental epidemiology. Current substantive research topics of interest, on which my work in collaboration with both international and Japanese colleagues, focus mainly on the impacts of weather and global climate change on health but include health risks of air pollution
FaramarzSamie, MD, PhD is the director of Mohs Surgery and Cutaneous Oncology at Dartmouth-Hitchcock Medical Center and an Assistant Professor of Surgery (Dermatology) at the Geisel School of Medicine at Dartmouth College. He has published in multiple journals and also serves on editorial boards related to his field.Dr. Samie received a BS in Bioengineering from Syracuse University and his MD and PhD from SUNY Upstate Medical University. He completed his internship in internal medicine at SUNY Upstate Medical University and residency in dermatology at the University of Rochester. He then completed a fellowship in Mohs surgery and cutaneous oncology at
FaramarzSamie, MD, PhD is the director of Mohs Surgery and Cutaneous Oncology at Dartmouth-Hitchcock Medical Center and an Assistant Professor of Surgery (Dermatology) at the Geisel School of Medicine at Dartmouth College. He has published in multiple journals and also serves on editorial boards related to his field.Dr. Samie received a BS in Bioengineering from Syracuse University and his MD and PhD from SUNY Upstate Medical University. He completed his internship in internal medicine at SUNY Upstate Medical University and residency in dermatology at the University of Rochester. He then completed a fellowship in Mohs surgery and cutaneous oncology at Roswell Park Cancer Institute.
Amir Feily is dermatologist and researcher in Skin and Stem Cell research Center of Tehran University of Medical Sciences, Tehran and Department of Dermatology of Jahrom University of Medical Sciences, Jahrom, Iran.He is the member of International Society of Dematology , European Academy of Dermatology, Editorial Board of Dermatology Report, Journal of Pigmentary disorder , Aperito Journal of Dermatology and Associated editor of Asian Journal of Dermatology. He is also the reviewer of many dermatologic journals such as British journal of Dermatology, International Journal of Dermatology, JEADV and etc. He has More than 70 high quality papers in Dermatology
Amir Feily is dermatologist and researcher in Skin and Stem Cell research Center of Tehran University of Medical Sciences, Tehran and Department of Dermatology of Jahrom University of Medical Sciences, Jahrom, Iran.He is the member of International Society of Dematology , European Academy of Dermatology, Editorial Board of Dermatology Report, Journal of Pigmentary disorder , Aperito Journal of Dermatology and Associated editor of Asian Journal of Dermatology. He is also the reviewer of many dermatologic journals such as British journal of Dermatology, International Journal of Dermatology, JEADV and etc. He has More than 70 high quality papers in Dermatology and Pharmacology. His recent two awards were 2013 Global Education Award, granted by International Society of Dermatology (IJD) and ImrichSarkani Non-European Memorial Scholarship awarded at 23rd EADV Congress Amsterdam, the Netherland 2014. Research interest includes Dermatology: Vitiligo, melasma,Psoriasis and papulosquamous disorders, Pharmacology: New drugs and mechanisms and new hypothesis, Immunology and autoimmune disorders.
Dr. Taheriis a house staff in Department of Internal Medicine at Wake Forest School of Medicine. He completed his medical school, internship, and dermatology residency at Tehran University of Medical Science.He joined the Center for Dermatology Research at Wake Forest University as a researcher at 2012. Dr. Taheri serves on the editorial board of Journal of Dermatological Treatment and journal of Experimental Dermatology and Clinical Research. His chief clinical and research interests are psoriasis, eczema, autoimmune diseases and the dermatologic manifestations of systemic diseases, wound healing and scar prevention,as well as electrosurgery. He is a researcher and expert in the
Dr. Taheriis a house staff in Department of Internal Medicine at Wake Forest School of Medicine. He completed his medical school, internship, and dermatology residency at Tehran University of Medical Science.He joined the Center for Dermatology Research at Wake Forest University as a researcher at 2012. Dr. Taheri serves on the editorial board of Journal of Dermatological Treatment and journal of Experimental Dermatology and Clinical Research. His chief clinical and research interests are psoriasis, eczema, autoimmune diseases and the dermatologic manifestations of systemic diseases, wound healing and scar prevention,as well as electrosurgery. He is a researcher and expert in the field of effects of high frequency electrical currents on biological tissues.
Dr. Catherine Olsen is a Senior Research Officer from the Cancer Control Group of the QIMR Berghofer Medical Research Institute and an Honorary Senior Research Fellow with the University of Queensland. Her primary area of research is melanoma and cancers of the skin, focusing on the environmental and genetic factors that cause these cancers.
Dr. Catherine Olsen is a Senior Research Officer from the Cancer Control Group of the QIMR Berghofer Medical Research Institute and an Honorary Senior Research Fellow with the University of Queensland. Her primary area of research is melanoma and cancers of the skin, focusing on the environmental and genetic factors that cause these cancers.
Dr. Mohamed Hassan is the leader of the Molecular Tumor Therapy group at 'Institut National de la Sante et de la Recherche Medicale' (INSERM), and Dental Faculty, University of Strasbourg, Strasbourg, France, and Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, USA. He was the Group leader of the Molecular Tumor Therapy up to Dec. 2011 at the University Hospital of Duesseldorf, Germany. Currently, He is Group leader of. Dr. Hassan earned his Bachelor of Science in chemistry and Zoology from the University of Zagazig, and earnd BSc, MSc, in Biomedical Science from the University of duesseldorf. Dr. Hassan
Dr. Mohamed Hassan is the leader of the Molecular Tumor Therapy group at 'Institut National de la Sante et de la Recherche Medicale' (INSERM), and Dental Faculty, University of Strasbourg, Strasbourg, France, and Cancer Institute, University of Mississippi Medical Center, Jackson, Mississippi, USA. He was the Group leader of the Molecular Tumor Therapy up to Dec. 2011 at the University Hospital of Duesseldorf, Germany. Currently, He is Group leader of. Dr. Hassan earned his Bachelor of Science in chemistry and Zoology from the University of Zagazig, and earnd BSc, MSc, in Biomedical Science from the University of duesseldorf. Dr. Hassan earned his PhD in Molecular Medicine/ Viral Oncology from the University of Duessledorf, Duesseldorf, Germany. Dr. Hassan specialized in Cancer Research, with particular interests in the field Molecular Tumor Therapies and Cancer stem- like cells. He is the recipient of Robert Frank award from International Association of Dental Research (IADR ) 2007, and Japanese society of internal medicine award, 2011. Dr. Hassan published more than 50 publications in the field of Cancer Research and Infectious Diseases. In addition, Dr. Hassan is editorial board member of many international Journals. Also, Dr. Hassan is invited Reviewer by many of international Peer review journals.
Haichang LI, DVM, PhD is an assistant professor in the department of surgery, The Ohio State University Wexner Medical Center. His research focuses on skin wound healing, scarring, and epidermal stem cell. He obtained his Ph.D. degree from Gifu University, Japan. Dr. Li also holds a veterinary medicine (D.V.M) degree from China. Following his Ph.D. studies in developmental biology and genetics, He finished his postdoc training in neuroscience at the Riken-Brain Science Institute of Japan, and Rutgers University-Robert Wood Johnson Medical School of USA. In addition, Dr. Li is also a registered patent agent of US patent and Trademark Office
Haichang LI, DVM, PhD is an assistant professor in the department of surgery, The Ohio State University Wexner Medical Center. His research focuses on skin wound healing, scarring, and epidermal stem cell. He obtained his Ph.D. degree from Gifu University, Japan. Dr. Li also holds a veterinary medicine (D.V.M) degree from China. Following his Ph.D. studies in developmental biology and genetics, He finished his postdoc training in neuroscience at the Riken-Brain Science Institute of Japan, and Rutgers University-Robert Wood Johnson Medical School of USA. In addition, Dr. Li is also a registered patent agent of US patent and Trademark Office (USPTO).
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97